171 related articles for article (PubMed ID: 1517014)
1. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. I. Synthesis and biological activity.
Said-Nejad OE; Felder ER; Mierke DF; Yamazaki T; Schiller PW; Goodman M
Int J Pept Protein Res; 1992 Feb; 39(2):145-60. PubMed ID: 1517014
[TBL] [Abstract][Full Text] [Related]
2. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M
Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
Schiller PW; Nguyen TM; Maziak LA; Wilkes BC; Lemieux C
J Med Chem; 1987 Nov; 30(11):2094-9. PubMed ID: 2822930
[TBL] [Abstract][Full Text] [Related]
5. Cyclic retro-inverso dipeptides with two aromatic side chains. I. Synthesis.
Nunami K; Yamazaki T; Goodman M
Biopolymers; 1991 Nov; 31(13):1503-12. PubMed ID: 1814500
[TBL] [Abstract][Full Text] [Related]
6. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling.
Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL
J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993
[TBL] [Abstract][Full Text] [Related]
7. Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge.
Filip K; Oleszczuk M; Pawlak D; Wojcik J; Chung NN; Schillerc PW; Izdebski J
J Pept Sci; 2003 Oct; 9(10):649-57. PubMed ID: 14620130
[TBL] [Abstract][Full Text] [Related]
8. Opioid peptides. Partially modified retro-inverso dermorphin analogues. XIII.
Marastoni M; Balboni G; Tomatis R; Salvadori S; Borea PA; Uccelli L
Farmaco; 1989 Nov; 44(11):1083-93. PubMed ID: 2562001
[TBL] [Abstract][Full Text] [Related]
9. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
Yamazaki T; Nunami K; Goodman M
Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
[TBL] [Abstract][Full Text] [Related]
10. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
11. Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.
Filip K; Oleszczuk M; Wójcik J; Chung NN; Schiller PW; Pawlak D; Zieleniak A; Parcińska A; Witkowska E; Izdebski J
J Pept Sci; 2005 Jun; 11(6):347-52. PubMed ID: 15635652
[TBL] [Abstract][Full Text] [Related]
12. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
[TBL] [Abstract][Full Text] [Related]
13. Cyclic and acyclic partial retro-inverso enkephalinamides: Mu receptor selective enzyme resistant analogs.
Berman JM; Goodman M; Nguyen TM; Schiller PW
Biochem Biophys Res Commun; 1983 Sep; 115(3):864-70. PubMed ID: 6312999
[TBL] [Abstract][Full Text] [Related]
14. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
15. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
16. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological activity of partially modified retro-inverso dermorphin tetrapeptides.
Salvadori S; Marastoni M; Balboni G; Sarto GP; Tomatis R
J Med Chem; 1985 Jun; 28(6):769-74. PubMed ID: 4009598
[TBL] [Abstract][Full Text] [Related]
18. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
19. Conformation-activity relationships of cyclic dermorphin analogues.
Wilkes BC; Schiller PW
Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
[TBL] [Abstract][Full Text] [Related]
20. Conformational analysis of cyclic partially modified retro-inverso enkephalin analogues by proton NMR.
Mammi NJ; Goodman M
Biochemistry; 1986 Nov; 25(23):7607-14. PubMed ID: 3801437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
